-
Encainide (trade name Enkaid) is a
class Ic
antiarrhythmic agent. It is no
longer used
because of its
frequent proarrhythmic side effects. Iferanserin...
-
flecainide is co-administered with
other class Ic antiarrhythmics, such as
encainide. The risk of
proarrhythmia may also be
increased by hypokalemia. The risk...
-
higher with both
encainide and
flecainide at a mean follow-up
period of 10 months.
Within about two
years after enrollment,
encainide and
flecainide were...
-
contraindicated in such settings.
class Ic
agents include encainide, flecainide, moricizine, and propafenone.
Encainide is not
available in the
United States. Sodium...
-
responsible for PVCs. In CAST
study of
survivors of
myocardial infarction encainide and flecainide, it was
shown that,
though those drugs could suppress PVC...
- acids. Chocolate, Coffee, Tea Caffeine, cocaine, beta-adrenergic
agonists Encainide,
Lorcainide Antiarrhythmic agent Electrophysiology study Merritt H. Raitt;...
-
enalkiren (INN)
enasidenib (INN)
enazadrem (INN)
Enbrel enbucrilate (INN)
encainide (INN)
enciprazine (INN)
enclomifene (INN)
encyprate (INN)
Endep endixaprine...
-
Antiarrhythmics (class I):
Ajmaline Aprindine Disopyramide Dronedarone Encainide Flecainide Lidocaine Lorajmine Lorcainide Mexiletine Moricizine Pilsicainide...
-
Antiarrhythmics (class I):
Ajmaline Aprindine Disopyramide Dronedarone Encainide Flecainide Lidocaine Lorajmine Lorcainide Mexiletine Moricizine Pilsicainide...
- Drug
Administration approval, the
antiarrhythmic agents flecainide and
encainide came to
market in 1986 and 1987 respectively. The non-randomized studies...
